Crossmark

Evaluation of severe hypoglycemia management in children and adolescents with type 1 diabetes in a Belgian tertiary pediatric care center: impact of intranasal glucagon and cost analysis

Crossref DOI link: https://doi.org/10.1007/s00431-025-05992-2

Published Online: 2025-01-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Harvengt, Antoine

Maure, Anaïs

Beckers, Maude

Boutsen, Laure

Brunelle, Chloé

Costenoble, Elise

Lysy, Philippe
Funding

Funding for this research was provided by:

Leona M. and Harry B. Helmsley Charitable Trust

Fondation Saint Luc
License Information

Text and Data Mining valid from 2025-01-30

Version of Record valid from 2025-01-30
More Information

Article History

Received: 24 October 2024

Revised: 20 December 2024

Accepted: 15 January 2025

First Online: 30 January 2025

Declarations

:

: The study was conducted in accordance with the ethical declaration of Helsinki and approved by the Hospital-Faculty Ethics Committee of the CUSL (2022/02/FEV/043).

: Informed consent was obtained from all subjects involved in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below